Core Insights - Bath & Body Works has faced significant challenges, leading to a downgrade by Telsey Advisory from "Outperform" to "Market Perform" on November 21, 2025, with the stock priced at $15.82 at that time [1][6] - The company's stock price dropped sharply by 25% following the announcement of declining sales and earnings, reflecting struggles in achieving growth [2][6] - The company reported a decrease in third-quarter sales by 1.2% to $1.59 billion and a drop in operating income from $218 million to $161 million year-over-year [3] Financial Performance - The adjusted earnings per share (EPS) for the third quarter was $0.35, missing analysts' expectations of $0.40 and down from $0.49 the previous year [3] - The company anticipates a minimum of $1.70 in fourth-quarter EPS, which is below forecasts [4] - Bath & Body Works has a market capitalization of approximately $3.39 billion, with a trading volume of 39.49 million shares [5] Market Conditions - The company is grappling with reduced consumer spending and broader macroeconomic pressures, along with additional strain from tariffs [4] - BBWI's stock has reached a five-year low, with fluctuations between a low of $15.43 and a high of $16.53 on the day of reporting [5]
Bath & Body Works (NYSE:BBWI) Faces Downgrade Amid Sales Decline